hoechst 33 342 staining solution (Beyotime)
Structured Review

Hoechst 33 342 Staining Solution, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 452 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hoechst+33+342+solution/Hoechst+33342+Staining+Solution/pmc13058820-80-0-5
Average 99 stars, based on 452 article reviews
Images
1) Product Images from "Forsythoside A Alleviates Neuroinflammatory Damage via Inhibiting TLR4 / NF ‐ κB / NLRP3 Activation‐Induced Astrocyte Pyroptosis in Cerebral Ischemia–Reperfusion"
Article Title: Forsythoside A Alleviates Neuroinflammatory Damage via Inhibiting TLR4 / NF ‐ κB / NLRP3 Activation‐Induced Astrocyte Pyroptosis in Cerebral Ischemia–Reperfusion
Journal: CNS Neuroscience & Therapeutics
doi: 10.1002/cns.70867
Figure Legend Snippet: FA suppresses OGD/R astrocyte pyroptosis and inflammation through hindering NLRP3 inflammasome activation. (A–B) Hoechst 33,342 and PI staining showed that 80 μM FA reduced pyroptosis in U251 cells after OGD/R, whereas NLRP3 agonist Nig resulted in increased pyroptosis (20×, 100 μm). (C) LDH assay showed that LDH release from U251 cells was increased following OGD/R FA inhibited LDH release, while Nig led to a rebound in LDH release. (D–E) Immunofluorescence co‐localization measured that OGD/R resulted in increased GSDMD‐N fluorescence intensity in U251 cells, FA treatment decreased GSDMD‐N level, and Nig attenuated the effect of FA (20×, 100 μm). (F–I) ELISA indicated that OGD/R resulted in increased IL‐1β, TNF‐α, IL‐18, and IL‐6 levels; FA treatment declined these inflammatory factors, but addition of Nig resulted in increased levels. (J–M) Western blot measured that OGD/R caused elevated iNOS, IL‐1β, and GSDMD‐N levels in U251 cells, and FA treatment decreased these protein levels, whereas the addition of Nig caused a rebound in these protein levels. (N) SEM to observe the morphological changes associated with pyroptosis in U251 cells. *** p < 0.001 vs. Control; ** p < 0.01 vs. OGD/R; && p < 0.01 vs. 80 μM FA.
Techniques Used: Activation Assay, Staining, Lactate Dehydrogenase Assay, Immunofluorescence, Fluorescence, Enzyme-linked Immunosorbent Assay, Western Blot, Control
